cilostamide has been researched along with Liver Cirrhosis in 1 studies
cilostamide: selective inhibitor of cyclic AMP phosphodiesterase & platelet aggregation; structure
Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.
Excerpt | Relevance | Reference |
---|---|---|
"Liver cirrhosis is associated with increased nitric oxide (NO) production in the vasculature." | 1.35 | PDEs1-5 activity and expression in tissues of cirrhotic rats reveal a role for aortic PDE3 in NO desensitization. ( Justiniano, H; Keravis, T; Lugnier, C; Maarouf, S; Sabra, R; Tahseldar-Roumieh, R, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Tahseldar-Roumieh, R | 1 |
Keravis, T | 1 |
Maarouf, S | 1 |
Justiniano, H | 1 |
Sabra, R | 1 |
Lugnier, C | 1 |
1 other study available for cilostamide and Liver Cirrhosis
Article | Year |
---|---|
PDEs1-5 activity and expression in tissues of cirrhotic rats reveal a role for aortic PDE3 in NO desensitization.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Aorta; Bile Ducts; Cyclic Nucleotide Phosphodiesterase | 2009 |